Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
321.00    -4.00 (-1.23%)
Bid:
314.00
Ask:
328.00
Spread: 14.00 (4.459%)
Market Cap: £40.73m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

17 Jan 2014 07:00

RNS Number : 8726X
BrainJuicer Group PLC
17 January 2014
 

 

 

 

Press Release 17 January 2014

 

 

BrainJuicer Group PLC

 ("BrainJuicer" and the "Company")

 

Trading update

 

Innovative, international online market researcher BrainJuicer Group PLC (AIM: BJU) today releases the following update on trading during its financial year ended 31 December 2013. The Company will announce its final results on 21 March 2014.

 

Revenue for the year increased by 17% to over £24m, reflecting continued encouraging trading over the second half of the year. Our core UK and US businesses both performed well, and all of our operations, with the exception of Germany, delivered increased revenue. The results were bolstered by an excellent fourth quarter, historically a strong but unpredictable quarter, during which revenues were well ahead of those in the disappointing comparable 2012 period.

 

Administrative costs were well controlled through the year, increasing by around 7%. The return of strong revenue growth and lower cost growth resulted in profits bouncing back strongly after the decline last year. Pre-tax profit for the year will be approximately £3.5m compared to £1.5m in 2012 and £2.8m in 2011, substantially beating the current market expectation.

 

Cash generation during 2013 was particularly strong. Even after returning £1.5m to shareholders in October via a 12p per share special dividend, the Company ended the year with a cash balance of £6.2m, compared with £3.8m at the end of 2012. BrainJuicer has no debt.

 

During 2013 the Company made further operational and strategic progress - enhancing its reputation and credibility. As testimony to this, in a recent global survey of over 2,000 market research practitioners (the Greenbook Industry Trends survey), the Company was voted the most innovative market research firm for the third year in a row. BrainJuicer's approaches, centred on Behavioural Science, continue to gain endorsement within major international clients, and this bodes well for further long term growth.

 

The Company can be found at www.brainjuicer.com.

 

 

- Ends -

 

 

For further information, please contact:

 

BrainJuicer Group PLC

John Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000

James Geddes, Chief Financial Officer www.brainjuicer.com

 

Canaccord Genuity Limited

Simon Bridges / Henry Fitzgerald-O'Connor Tel: +44 (0)20 7523 8000

www.canaccordgenuity.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUNAVRSUAAAAR
Date   Source Headline
7th Jan 20227:00 amRNSShare Buyback Programme
4th Jan 20222:00 pmRNSDirectorate Change
30th Nov 20214:51 pmRNSDirector Dealings
30th Nov 20217:00 amRNSINTERIM RESULTS
9th Nov 20217:00 amRNSComplaint for Trademark Infringement
29th Oct 20211:24 pmRNSGrant of Options
20th Oct 20217:00 amRNSTrading Update
13th Aug 20215:24 pmRNSAnnual General Meeting
13th Aug 20217:00 amRNSTrading Update for the Annual General Meeting
4th Aug 20216:15 pmRNSUpdate re 2021 AGM
20th Jul 20212:30 pmRNSAnnual Report and Notice of AGM
14th Jul 20217:00 amRNSFinal Results
23rd Jun 202112:30 pmRNSNotice of Results
21st May 20217:00 amRNSExercise of Options and Total Voting Rights
17th May 202112:12 pmRNSDirector/PDMR Shareholding
28th Apr 20211:08 pmRNSDirector/PDMR Shareholding
23rd Apr 202111:16 amRNSCorrection re Directors Dealings
23rd Apr 20219:40 amRNSExercise of Options, Directors Dealings and TVR
21st Apr 20217:00 amRNSTrading Update
30th Mar 20217:00 amRNSChange in Executive Job Titles
15th Feb 202112:42 pmRNSBoard Changes
12th Feb 202111:00 amRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSDirector/PDMR Shareholding
2nd Dec 20204:30 pmRNSGrant of Options
27th Nov 20207:00 amRNSDirector/PDMR Shareholding
17th Nov 20206:27 pmRNSDirector/PDMR Shareholding
17th Nov 20207:00 amRNSInterim Results
14th Oct 20207:00 amRNSTrading Update
12th Oct 20201:40 pmRNSHolding(s) in Company
7th Oct 20202:33 pmRNSHolding(s) in Company
24th Sep 20204:08 pmRNSHolding(s) in Company
4th Aug 20209:39 amRNSDirector/PDMR Shareholding - Replacement
3rd Aug 20205:33 pmRNSDirector/PDMR Shareholding
31st Jul 20206:34 pmRNSResult of AGM
6th Jul 20204:33 pmRNSAnnual Report and Notice of AGM
3rd Jul 202012:22 pmRNSDirector/PDMR Shareholding
2nd Jul 202010:04 amRNSDirector/PDMR Shareholding
30th Jun 20207:00 amRNSFinancial results to 31 March 2020
26th Jun 20202:00 pmRNSExercise of Options and Total Voting Rights
26th Jun 20207:00 amRNSDirectorate Change
26th Jun 20207:00 amRNSDirectorate Change
27th Apr 20207:00 amRNSTrading Update
3rd Apr 20207:00 amRNSChief Financial Officer Resignation
24th Mar 20204:40 pmRNSSecond Price Monitoring Extn
24th Mar 20204:36 pmRNSPrice Monitoring Extension
6th Feb 20207:00 amRNSTrading Update and Planned Share Buyback
23rd Dec 20193:30 pmRNSExercise of Options and Total Voting Rights
7th Nov 20199:29 amRNSDividend Declaration
7th Nov 20197:00 amRNSInterim Results
14th Oct 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.